Odyssey Therapeutics Appoints Timothy P. Walbert and Ian F. Smith to Board of Directors
Key Highlights Timothy P. Walbert: Former Chairman, President & CEO of Horizon Therapeutics, instrumental in $28.3 billion acquisition…
Browsing Tag
Horizon Therapeutics
1 post